Navigation Links
Latin America Pharmaceutical Contract Manufacturing Services Market 2014-2017 and 2025 - Research and Markets
Date:4/20/2017

DUBLIN, April 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, Venezuela), And Segment Forecasts, 2014 - 2025" report to their offering.

The Latin American pharmaceutical contract manufacturing services market is anticipated to reach USD 21.0 billion by 2025

Low drug registration cost in Latin American countries and continuous economic growth are the key factors contributing to progress in this region. Moreover, Latin America offers higher recruitment rates and relatively high competitive prices in comparison to United States and other European countries.

A forementioned fact pronounces the trend of shifting Contract Manufacturing/Research Organizations (CMO/CRO)'s attention to Latin American countries such as Brazil, Mexico, Argentina, and Colombia. Ongoing adjustment in Latin America to reduce the commodity prices and domestic political turbulence in each country is expected to shape region's economic growth there by driving revenue generation in the outsourcing market for pharmaceutical development.

Further Key Findings from the study suggest:

  • Contract manufacturing services accounted for the largest share owing to wide range of services offered by the CMO's located herein for therapeutic drug development
  • API/Bulk drug development services accounted for the largest share over the other segments as companies continue to invest for API production capacity enhancement
  • Rising inclination of drug manufacturers to focus on core competencies such as R&D are observed to have a major impact on the yearly growth of contract research organizations
  • Brazil held the largest share with respect to revenue generation in 2015
  • Government's current initiative to ensure GMP compliance among small and medium-sized pharma companies has contributed for the large share of Brazil
  • Chile is expected to witness the fastest growth over the forecast period.
  • Presence of companies offering bioanalytical, biomarker discovery, assay development, and cGMP analytical services can be attributed for the estimated growth
  • Key players contributing in this market are Lonza; Charles River Laboratories S.A; Jubilant Life Sciences Limited; Boehringer Ingelheim GmbH; Pfizer, Inc. (Pfizer CenterOne); Albany Molecular Research, Inc; QuintilesIMS; and Pharmaceutical Product Development, LLC.
  • These entities are involved in collaborations with therapeutic research organizations in order to enhance their industrial presence

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Drug shortage leading to drive demand for pharmaceutical development
3.1.1.2 Commercial success of biologics for clinical use
3.1.1.3 Lower drug registration costs and improving economic condition of Latin America
3.1.2 Market restraint analysis
3.1.2.1 Limited outsourcing among big pharma companies' clients
3.1.2.2 Regulatory issues pertaining to the drug approval
3.2 Penetration & Growth Prospect Mapping, 2015
3.3 Latin America Pharmaceutical Contract Manufacturing Services- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's

4 Latin America Pharmaceutical Contract Manufacturing Service Market: Services Estimates & Trend Analysis
4.1 Latin America Pharmaceutical Contract Manufacturing Services Market: Service Movement Analysis
4.2 Manufacturing
4.2.2 API/bulk drugs
4.2.3 Advanced drug delivery formulations
4.2.4 Packaging
4.2.5 Finished dose formulations
4.2.5.2 Solid finished dose formulations
4.2.5.3 Liquid formulations
4.2.5.4 Semi-solid formulations
4.3 Research
4.3.2 Oncology
4.3.3 Vaccines
4.3.4 Inflammation & immunology
4.3.5 Cardiology
4.3.6 Neuroscience
4.3.7 Other

5 Latin America Pharmaceutical Contract Manufacturing Service Market: Country Estimates & Trend Analysis
5.1 Latin America Pharmaceutical Contract Manufacturing Services Market Share By Country, 2015& 2025
5.2 Latin America Pharmaceutical Contract Manufacturing Services Market, 2014 - 2025 (USD Million)
5.3 Brazil
5.4 Mexico
5.4.2 Colombia
5.4.3 Argentina
5.4.4 Chile
5.4.5 Venezuela
5.4.6 Rest of Latin America

6 Competitive Landscape

  • Boehringer Ingelheim GmbH
  • Lonza
  • Grifols S.A
  • Jubilant Life Sciences Limited
  • Pfizer, Inc. (Pfizer CenterOne)
  • Charles River Laboratories International, Inc.
  • Albany Molecular Research, Inc.
  • Covance, Inc. (LabCorp)
  • QuintilesIMS
  • Baxter BioPharma Solutions
  • Aenova Holding GmbH
  • Vetter Pharma
  • Valeant Pharmaceuticals International Inc.
  • Ligand Pharmaceuticals, Inc.
  • Pharmaceutical Product Development, LLC
  • Recipharm AB.
  • AbbVie, Inc.
  • Famar Health Care Services
  • Catalent Pharma Solutions
  • West Pharmaceutical Services, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/2wz4mv/latin_america

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/latin-america-pharmaceutical-contract-manufacturing-services-market-2014-2017-and-2025---research-and-markets-300442474.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Additive Orthopaedics Announces FDA Clearance of their Locking Lattice Plating System for the Global Extremities Market
2. Healthcare Stocks on Investors Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
3. MagBio Genomics Launches a Novel Solution for Isolation of Circulating Cell-Free DNA (ccfDNA) From Stabilized Plasma Sample
4. Palatin Technologies To Present At The 29th Annual ROTH Conference
5. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February 9, 2017
6. Paragon 28 announces launch of unprecedented small bone fixation system for foot & ankle-Baby Gorilla Mini Plating System
7. TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients
8. NewVac Reports Primary Endpoint Met in Phase II Clinical Trial of Quisinostat in Combination with Paclitaxel and Carboplatin in Platinum-Resistant Ovarian Cancer
9. New Video: Translating science into new medicines
10. Palatin Technologies Closes on $16.5 Million Financing
11. Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic Markets June 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer Dr. ... colleagues, skilled nursing facility medical directors and other clinicians at various events in ... , "At many of these conferences we get to educate other physicians, facility ...
Breaking Medicine News(10 mins):